Retinoblastoma mutation predicts poor outcomes in advanced non small cell lung cancer.

Cancer Med · 2019 · PMC6488103 · PMID 30773851

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

A potential difference to explain our highly significant results is that our study focused on locally advanced and advanced NSCLC, as opposed to the early stage disease examined by all the other studies, including TCGA.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.